Guidance

Rapid Review Panel: product evaluation statements

Evaluations made by the Rapid Review Panel (RRP) on submitted products.

Documents

2203-01: Synexis Dry Hydrogen Peroxide Biodefence System

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1812-01: Ultracleanse (b)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

2903-01: Prevacept infection control, inc PrevaCept Lock Solution

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1803-01: Cupron Inc - Cupron Medical Textiles

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1603-01: Chloraderm

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1511-01: Chrisal PIP range

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1511-02: Novapharm - Gettinge Prion Detergent

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1508-01: AntiBac Coating Ltd Antibac Coating

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1508-02: Cutting Corners Mitre Makers Ltd Internal Trimitre

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1505-01: Cutting Corners Mitre Makers Ltd – Internal Floormitre

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

1505-02: Bowen Medical – Cuff-Guard

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These documents set out the individual product evaluations of the RRP starting May 2015. The RRP may make one of the following evaluations.

  • E1: Basic research and development, validation and recent in use evaluations and trials have shown that the product is likely to have benefit(s) in improving infection prevention and control (IPC) interventions to reduce healthcare associated infections (HCAI) within the NHS; the RRP recommends considering the use of this product in the NHS to improve IPC interventions to reduce HCAIs
  • E2: Basic research and development has been completed and the product may have potential value; the RRP recommends in use evaluations and trials to demonstrate improved efficiency or efficacy in improving infection prevention and control to reduce healthcare associated infections are considered within an active NHS clinical setting
  • E3: Basic research and development has begun and the product may have value; the product requires head-to-head trials against existing available products to demonstrate improved efficiency or efficacy in improving infection prevention and control interventions to reduce healthcare associated infection
  • E4: Potentially useful product but insufficient evidence presented; further research and development with the product as intended to be used in the NHS is required to demonstrate improvements in infection prevention and control interventions to reduce healthcare associated infections before it is ready for in use evaluation within the NHS
  • E5: Evidence presented does not demonstrate that the product is more efficient or efficacious at improving infection prevention and control interventions to reduce healthcare associated infections than other available products currently in use
  • E6: Evidence presented does not demonstrate that the product has a contribution to make to improvements in infection prevention and control interventions to reduce healthcare associated infections
  • NE: (No Evaluation); this product is outside the remit for review or the evidence has been submitted in a way which does not allow for an evaluation by the Rapid Review Panel
Published 7 May 2015
Last updated 9 August 2019 + show all updates
  1. Added '2203-01: Synexis Dry Hydrogen Peroxide Biodefence System' document.

  2. Added '1812-01: Ultracleanse (b)' document.

  3. Added: 2903-01: Prevacept Infection Control, inc PrevaCept Lock Solution.

  4. Added 1803-01 Cupron Inc - Cupron Medical Textiles evaluation statement.

  5. Published 1603-01: Chloraderm RRP application.

  6. Added evaluations from November 2015.

  7. Updated with evaluations from August 2015.

  8. First published.